Selenium in oxidation state zero is a potent and selective anti-leukemia/lymphoma agent

被引：0
|
作者：
Sieber, F [1 ]
机构：
[1] Med Coll Wisconsin, Milwaukee, WI 53226 USA
来源：
EXPERIMENTAL HEMATOLOGY | 2003年 / 31卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
178
引用
收藏
页码：119 / 120
页数：2
相关论文
共 50 条
  • [21] A Kinase Inhibitor with Anti-Pim Kinase Activity is a Potent and Selective Cytotoxic Agent Toward Acute Myeloid Leukemia
    Bjornstad, Ronja
    Aesoy, Reidun
    Bruserud, Oystein
    Brenner, Annette K.
    Giraud, Francis
    Dowling, Tara Helen
    Gausdal, Gro
    Moreau, Pascale
    Doskeland, Stein Ove
    Anizon, Fabrice
    Herfindal, Lars
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (03) : 567 - 578
  • [22] Anti-leukemia activities of selenium nanoparticles embedded in nanotube consisted of triple-helix β-D-glucan
    Jin, Yanxia
    Cai, Liqin
    Yang, Qian
    Luo, Ziyi
    Zhang, Lina
    Zhou, Fuling
    CANCER RESEARCH, 2020, 80 (16)
  • [23] A single-chain variable fragment antibody against anti-leukemia agent, harringtonine as a tool for immunomodulation
    Komatsu, S.
    Sakamoto, S.
    Yusakul, G.
    Putalun, W.
    Miyamoto, T.
    Tanaka, H.
    Morimoto, S.
    PLANTA MEDICA, 2016, 82
  • [24] A Novel Approach for Systematic Delivery of a Hydrophobic Anti-Leukemia Agent Tamibarotene Mediated by Nanostructured Lipid Carrier
    Liu, Xin
    Wang, Zhonglan
    Feng, Ruihua
    Hu, Yue
    Huang, Guihua
    JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2013, 9 (09) : 1586 - 1593
  • [25] A new hypomethylating agent, OR-2100, resists cytidine deaminase with oral absorbability and anti-leukemia effects
    Ureshino, Hiroshi
    Watanabe, Tatsuro
    Tohyama, Kaoru
    Okada, Seiji
    Harada, Hironori
    Ushijima, Toshikazu
    Kimura, Shinya
    CANCER SCIENCE, 2021, 112 : 674 - 674
  • [26] Novel nitrogen mustard-artemisinin hybrids with potent anti-leukemia action through DNA damage and activation of GPx
    Dai, Tianzhi
    Lin, Lan
    Chen, Huan
    Lu, Wenyu
    Yang, Xuelian
    Yang, Li
    Liu, Ying
    Cui, Jichun
    Sun, Dequn
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 244
  • [27] CpG oligodeoxynucleotides (ODNs) are potent stimulators of anti-leukemia and alloresponses in naive and bone marrow transplant (BMT) recipients.
    Blazar, BR
    Panoskaltsis-Mortari, A
    Krieg, AM
    Taylor, PA
    BLOOD, 2000, 96 (11) : 475A - 475A
  • [28] Molecular Structure, Spectroscopic Investigation, Docking and in Vitro Cytotoxicity Studies of 7-Methoxycoumarin as anti-Leukemia Agent
    Ramuthai, M.
    Jeyavijayan, S.
    Jayram, Naidu Dhanpal
    POLYCYCLIC AROMATIC COMPOUNDS, 2022, 42 (10) : 6988 - 7009
  • [29] IL-15 Primes a Highly Potent Anti-Leukemia Response By CD56bright NK Cells
    Romee, Rizwan
    Leone, Jeffrey W.
    Schneider, Stephanie E.
    Sullivan, Ryan P.
    Fehniger, Todd A.
    BLOOD, 2013, 122 (21)
  • [30] Marine Cytotoxin Santacruzamate A Derivatives as Potent HDAC1-3 Inhibitors and Their Synergistic Anti-Leukemia Effects with Venetoclax
    Hao, Wanting
    Wang, Leyan
    Xu, Tongqiang
    Jia, Geng
    Jiang, Yuqi
    Qin, Chong
    Li, Xiaoyang
    MARINE DRUGS, 2024, 22 (06)
12345